Condensed Statements of Changes in Stockholders' Deficit - USD ($) $ in Thousands	Total	Public Equity Offering - ATM	Public Equity Offering	Private equity	Warrant exercises	Public equity	Common Stock	Common Stock Public Equity Offering - ATM	Common Stock Public Equity Offering	Common Stock Warrant exercises	Common Stock Public equity	Additional Paid-in Capital	Additional Paid-in Capital Public Equity Offering - ATM	Additional Paid-in Capital Public Equity Offering	Additional Paid-in Capital Private equity	Additional Paid-in Capital Warrant exercises	Additional Paid-in Capital Public equity	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022							54,827,734
Beginning balance at Dec. 31, 2022	$ (118,554)						$ 55					$ 192,598						$ (311,207)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)							1,078,622
Common Stock issued under public equity offering	993						$ 1					992
Costs of common stock issued under public equity offering-ATM	(77)											(77)
Share-based compensation expense	344											344
Vested restricted stock units, net (in shares)							16,005
Vested restricted stock units, net	(8)											(8)
Other	(1)											(1)
Net (loss) income	8,068																	8,068
Ending balance (in shares) at Mar. 31, 2023							55,922,361
Ending balance at Mar. 31, 2023	(109,235)						$ 56					193,848						(303,139)
Beginning balance (in shares) at Dec. 31, 2022							54,827,734
Beginning balance at Dec. 31, 2022	(118,554)						$ 55					192,598						(311,207)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	2,276
Ending balance (in shares) at Jun. 30, 2023							61,615,959
Ending balance at Jun. 30, 2023	(106,651)						$ 62					202,218						(308,931)
Beginning balance (in shares) at Dec. 31, 2022							54,827,734
Beginning balance at Dec. 31, 2022	(118,554)						$ 55					192,598						(311,207)
Ending balance (in shares) at Dec. 31, 2023							68,533,085
Ending balance at Dec. 31, 2023	(106,487)						$ 69					212,521						(319,077)
Beginning balance (in shares) at Mar. 31, 2023							55,922,361
Beginning balance at Mar. 31, 2023	(109,235)						$ 56					193,848						(303,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)							1,981,937			3,689,452
Common Stock issued under public equity offering	4,409				$ 3,542		$ 2			$ 4		4,407				$ 3,538
Costs of common stock issued under public equity offering-ATM	(235)											(235)
Shares issued under employee stock purchase plan (in shares)							18,699
Shares issued under employee stock purchase plan	31											31
Share-based compensation expense	631											631
Vested restricted stock units, net (in shares)							3,510
Vested restricted stock units, net	(3)											(3)
Other	1											1
Net (loss) income	(5,792)																	(5,792)
Ending balance (in shares) at Jun. 30, 2023							61,615,959
Ending balance at Jun. 30, 2023	(106,651)						$ 62					202,218						(308,931)
Beginning balance (in shares) at Dec. 31, 2023							68,533,085
Beginning balance at Dec. 31, 2023	(106,487)						$ 69					212,521						(319,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)								4,557,220	16,666,667
Common Stock issued under public equity offering		$ 12,385	$ 75,000					$ 4	$ 17				$ 12,381	$ 74,983
Costs of common stock issued under public equity offering-ATM		$ (410)	$ (5,187)										$ (410)	$ (5,187)
Share-based compensation expense	1,580											1,580
Vested restricted stock units, net (in shares)							490,359
Vested restricted stock units, net	$ (893)											(893)
Options exercises, net (in shares)	231,400
Options exercised, net	$ 539
Net (loss) income	(12,828)																	(12,828)
Ending balance (in shares) at Mar. 31, 2024							90,478,731
Ending balance at Mar. 31, 2024	(36,301)						$ 90					295,514						(331,905)
Beginning balance (in shares) at Dec. 31, 2023							68,533,085
Beginning balance at Dec. 31, 2023	(106,487)						$ 69					212,521						(319,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(15,573)
Ending balance (in shares) at Jun. 30, 2024							91,059,760
Ending balance at Jun. 30, 2024	(35,479)						$ 91					299,080						(334,650)
Beginning balance (in shares) at Mar. 31, 2024							90,478,731
Beginning balance at Mar. 31, 2024	(36,301)						$ 90					295,514						(331,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)											559,801
Common Stock issued under public equity offering						$ 2,520					$ 1						$ 2,519
Costs of common stock issued under public equity offering-ATM				$ (158)		$ (359)									$ (158)		$ (359)
Shares issued under employee stock purchase plan (in shares)							17,716
Shares issued under employee stock purchase plan	46											46
Share-based compensation expense	1,523											1,523
Vested restricted stock units, net (in shares)							3,512
Vested restricted stock units, net	(5)											(5)
Net (loss) income	(2,745)																	(2,745)
Ending balance (in shares) at Jun. 30, 2024							91,059,760
Ending balance at Jun. 30, 2024	$ (35,479)						$ 91					$ 299,080						$ (334,650)